His scientific interests lie mostly in Internal medicine, Endocrinology, Pheochromocytoma, Primary aldosteronism and Blood pressure. His study in Cardiology extends to Internal medicine with its themes. His study on Catecholamine, Adenosine and Diabetes mellitus is often connected to Stroke etiology as part of broader study in Endocrinology.
His Pheochromocytoma study combines topics from a wide range of disciplines, such as Epinephrine and Paraganglioma. His Primary aldosteronism research is multidisciplinary, relying on both Hyperaldosteronism, Surgery and Pediatrics. As a part of the same scientific family, Jacques W.M. Lenders mostly works in the field of Blood pressure, focusing on Anesthesia and, on occasion, Baroreflex and Orthostatic vital signs.
His primary scientific interests are in Internal medicine, Endocrinology, Pheochromocytoma, Blood pressure and Primary aldosteronism. In his research on the topic of Internal medicine, Diastole is strongly related with Cardiology. Many of his studies on Endocrinology apply to Forearm as well.
Jacques W.M. Lenders has researched Pheochromocytoma in several fields, including Multiple endocrine neoplasia type 2 and Paraganglioma. His studies deal with areas such as Hemodynamics, Anesthesia and Surgery as well as Blood pressure. While the research belongs to areas of Primary aldosteronism, Jacques W.M. Lenders spends his time largely on the problem of Adenoma, intersecting his research to questions surrounding KCNJ5.
His primary areas of investigation include Internal medicine, Pheochromocytoma, Primary aldosteronism, Endocrinology and Paraganglioma. His Internal medicine study deals with Cardiology intersecting with Diastole and Presyncope. His work carried out in the field of Pheochromocytoma brings together such families of science as Catecholamine, Chromaffin cell and Epinephrine.
His research in Primary aldosteronism intersects with topics in Quality of life and Adrenalectomy. His work in the fields of Sympathetic Paraganglioma and Body mass index overlaps with other areas such as Perioperative management. His Paraganglioma research includes elements of Cancer research, Gene mutation, Functional imaging, Disease and Genetic testing.
The scientist’s investigation covers issues in Primary aldosteronism, Paraganglioma, Urology, Pheochromocytoma and Internal medicine. The study incorporates disciplines such as Hyperaldosteronism, Hyperplasia and Adrenalectomy in addition to Primary aldosteronism. His Paraganglioma study integrates concerns from other disciplines, such as Phenotype, Cancer research, Disease and Transcriptome.
In his research, Metanephrine and Normetanephrine is intimately related to Metanephrines, which falls under the overarching field of Urology. His studies in Pheochromocytoma integrate themes in fields like Catecholamine and Prospective cohort study. Many of his studies involve connections with topics such as Endocrinology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline
Jacques W.M. Lenders;Quan Yang Duh;Graeme Eisenhofer;Anne Paule Gimenez-Roqueplo.
The Journal of Clinical Endocrinology and Metabolism (2014)
Biochemical diagnosis of pheochromocytoma: which test is best?
Jacques W. M. Lenders;Karel Pacak;McClellan M. Walther;W. Marston Linehan.
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
Francien H van Nederveen;José Gaal;Judith Favier;Esther Korpershoek.
Lancet Oncology (2009)
Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results
Graeme Eisenhofer;David S. Goldstein;McClellan M. Walther;Peter Friberg.
The Journal of Clinical Endocrinology and Metabolism (2003)
An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism
Gian Paolo Rossi;Richard J. Auchus;Morris Brown;Jacques W.M. Lenders;Jacques W.M. Lenders.
Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
G. Eisenhofer;J. W. M. Lenders;W. M. Linehan;M. M. Walther.
The New England Journal of Medicine (1999)
Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes
Graeme Eisenhofer;McClellan M. Walther;Thanh Truc Huynh;Sheng Ting Li.
The Journal of Clinical Endocrinology and Metabolism (2001)
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
Tracy A Williams;Tracy A Williams;Jacques W M Lenders;Jacques W M Lenders;Paolo Mulatero;Jacopo Burrello.
The Lancet Diabetes & Endocrinology (2017)
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Nelly Burnichon;Alberto Cascón;Francesca Schiavi;Nicole Paes Morales.
Clinical Cancer Research (2012)
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
Jean Pierre Bayley;Henricus P.M. Kunst;Alberto Cascon;Maria Lourdes Sampietro.
Lancet Oncology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: